Seeing Is Believing
Healthcare - Sector
Bluebird bio's activity chart (see below) currently has 404 price targets and 338 ratings on display.
Analysts average stock forecasts to be materialized ratio is 52.43% with an average time for these price targets to be met of 145.6 days.
Most recent stock forecast was given by from BARCLAYS on 31-Mar-2025.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Aug-2024
$8
$3.03 (60.97%)
1 years 6 months 22 days ago
(31-Mar-2025)
5/6 (83.33%)
$3.12 (63.93%)
189
Hold Since 10-Aug-2021
$5
$0.03 (0.60%)
1 years 7 months 29 days ago
(24-Feb-2025)
2/3 (66.67%)
$0.95 (23.46%)
61
Sell Since 24-Feb-2025
$6.2
1 years 7 months 29 days ago
(24-Feb-2025)
1/2 (50%)
$-0.22 (-3.43%)
4
Hold Since 29-Mar-2021
$8
$3.03 (60.97%)
1 years 9 months 16 days ago
(07-Jan-2025)
1/2 (50%)
$-1.02 (-11.31%)
15
Buy Since 12-Dec-2023
$6
1 years 10 months 7 days ago
(16-Dec-2024)
3/3 (100%)
$-3.89 (-39.33%)
160
What is BLUE (Bluebird bio) average time for price targets to be met?
Which analyst most recently updated their price target on BLUE (Bluebird bio)?
Which analyst has the most public recommendations on BLUE (Bluebird bio)?
Which analyst is the currently most bullish on BLUE (Bluebird bio)?
Which analyst is the currently most reserved on BLUE (Bluebird bio)?